Research Groups and R&D Platforms: Diabetes
Research Group:
Neuroendocrine mechanisms in pathogenesis and therapeutics of cardiometabolic diseases
Eriika Savontaus
eriika.savontaus[at]utu.fi
Institute of Biomedicine,
University of Turku
TCDM - Turku Center for Disease Modeling
Basic research, Biomedicine, Cardiovascular diseases, Diabetes, Disease models, Drug target, Endocrinology, Metabolic diseases, Obesity, Pharmacology, Receptor, Target discovery
Research Group:
Bioactive natural compounds
Patrik Eklund
paeklund[at]abo.fi
Laboratory of Organic Chemistry,
Åbo Akademi University
Cancer, Diabetes, Hit to lead, Inflammation, Lead optimization, Natural Compounds, Natural products, NMR, Organic Chemistry, Organic compounds, Synthetic chemistry
Research Group:
Pharmacoepidemiology of statins and oral anticoagulants
Risto Huupponen
risto.huupponen(at)utu.fi
Institute of Biomedicine,
University of Turku
Biomedicine, Cardiovascular diseases, Clinical development, Clinical Medicine, Data mining, Diabetes, Epidemiology, Metabolic diseases, Obesity, Pharmacology
Research Group:
Immunogenetics of autoimmune diseases
Jorma Ilonen
jorma.ilonen[at]utu.fi
Institute of Biomedicine,
University of Turku
Autoimmune diseases, Basic research, Biomedicine, Diabetes, Epigenomics, Genetics, Genomics, Immunology, In Vitro Diagnostics, Infection, Polymorph analysis
R&D Platform:
Turku PET Centre
Turku PET Centre is a Finnish National Research Institute for the use of short-lived positron emitting isotopes in the field of medical research.
The scientific research strategy of the Turku PET Centre involves six major topics: Cardiovascular and Metabolic research, Brain research, Cancer research, Preclinical studies and Drug development, Radiochemistry research and Data processing and image analysis.
Collaboration between academia and industry is also active. The studies are carried out together with basic scientists, dedicated physicists and radiochemists, experienced clinical investigators and other professionals.
Cancer, Cardiovascular diseases, Clinical development, Diabetes, In Vivo Diagnostics, Obesity, PET, Preclinical development
Research Group:
PET imaging of neuropathological changes in animal models of Alzheimer’s disease
Merja Haaparanta-Solin
mehaaso[at]utu.fi
Turku PET Centre, Preclinical Imaging,
University of Turku
Ageing-related diseases, Antibodies, Autoimmune diseases, Basic research, Biochemistry, Biomarker, Biomedicine, Cardiovascular diseases, Diabetes, Disease models, Drug target, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Metabolic diseases, Nanoparticles, Neurological disorders, Organic compounds, PET, Pharmacology, Preclinical development, Receptor, Target discovery
